Tetrandrine and cancer - An overview on the molecular approach

Article ID	Journal	Published Year	Pages	File Type
8526018	Biomedicine & Pharmacotherapy	2018	9 Pages	PDF

Keywords

CYC RAF APC p38 ATG Cyt C LC3 IAP EGFR Bcl-xL FLIP HGF HRAS TNFR FADD GEF TRADD GSK 3β Cyclin CIP/KIP FDA Tumor suppressor proteins HAI-1 TNF Fas associated death domain CD 31 autophagy protein CDK interacting protein/Kinase inhibitory protein RAS PI3K CDK MMP NRAS KRAS FAS mTOR ICAM-1 NF-kB FGF Bcl-2 ERK BH3 Interacting Domain Death Agonist c-Met MKK Mitogen activated protein kinase kinase ROS ADAM adenomatous polyposis coli Akt interferon IFN interleukin Bax tetrandrine a disintegrin and metalloproteinase tBid truncated Bid Ink Apoptosis rat sarcoma Food and Drug Administration cytochrome c extracellular signal regulated kinase Hepatocyte growth factor apoptotic protease activating factor 1 Guanine nucleotide exchange factors FasL Growth factor Vascular Endothelial Growth Factor (VEGF)fibroblast growth factor tumor necrosis factor nuclear factor kappa-light-chain-enhancer of activated B cells Bioavailability phosphatidyl inositol 3 kinase rapidly accelerated fibrosarcoma TRAIL TNF-related apoptosis-inducing ligand matrix metalloproteinase Mouse double minute 2 MEK Multi drug resistance inhibitor of apoptosis protein mammalian target of rapamycin Phosphatase and tensin homologue wee protein kinase B mitogen activated protein kinase BAK BID Chk Pten glycogen synthase kinase 3 β Reactive oxygen species hepatocyte growth factor receptor Epithelial growth factor receptor tumor necrosis factor receptor death receptor

Related Topics

Health Sciences Medicine and Dentistry Oncology

Tetrandrine and cancer - An overview on the molecular approach

Authors

Bhagya N., Chandrashekar K.R.,